CBS NewsHealth
FDA orders vision-loss warning on GLP-1 drugs
The Food and Drug Administration says glucagon-like peptide-1 weight loss drugs must now carry warning labels about a possible increased risk of vision loss. The agency announced the change, but provided no further details about the risk.
This card is an AI-assisted summary of reporting published by CBS News. Read the original report before relying on it for medical, legal, financial, safety, or emergency decisions.